Blood Glucose Monitoring Systems Market Revenue Projected to Reach $24.67 Billion by 2030 with 6.8% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Blood Glucose Monitoring Systems Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The blood glucose monitoring systems market has shown strong growth in recent years. Its size is expected to expand from $17.66 billion in 2025 to $19 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion observed in prior periods can be attributed to factors such as the increasing global prevalence of diabetes, heightened awareness of glucose self-monitoring, the initial availability of invasive glucose meters and test strips, the broadening of home healthcare and outpatient diabetes management services, and a greater focus on glycemic control to lessen complications.
The blood glucose monitoring systems market size is expected to experience significant growth in the coming years. It will grow to **$24.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%**. This projected growth is driven by several factors, including the increasing demand for continuous glucose monitoring and flash monitoring systems, the rising adoption of wearable and implantable monitoring devices, a higher uptake of remote and connected diabetes management solutions, the growing penetration of non-invasive glucose sensing technologies, and the expanding use of monitoring systems in type 2, type 1, and gestational diabetes care. Major trends anticipated in the forecast period include the increasing adoption of continuous and real-time blood glucose monitoring solutions, a notable shift towards minimally invasive and non-invasive glucose monitoring technologies, the growing use of portable, home-based, and self-monitoring glucose devices, the expansion of blood glucose monitoring into preventive and chronic disease management, and a focus on enhancing accuracy, convenience, and patient control in diabetes care.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17097&type=smp
What Key Drivers Are Influencing The Growth Of The Blood Glucose Monitoring Systems Market?
The increasing number of individuals with diabetes is anticipated to fuel the expansion of the blood glucose monitoring systems market in the future. This surge in the diabetic population is attributed to elements like inactive lifestyles, poor dietary habits, an aging demographic, and inherited genetic tendencies. These blood glucose monitoring systems serve to track and regulate blood sugar concentrations, assisting in disease management and averting adverse health outcomes. As an illustration, in 2025, data from the International Diabetes Federation, a health body headquartered in Belgium, indicated that in 2024, approximately 589 million adults between the ages of 20 and 79 had diabetes, a figure expected to climb to 853 million by 2050, with over 4 in 5 of these adults living in low and middle income countries. Conditions such as being born outside the country of residence, inhabiting underprivileged regions, and possessing a disability are linked to elevated rates of diabetes. Consequently, the growing occurrence of the diabetic population will be a key driver for the blood glucose monitoring systems market.
What Major Segment Divisions Exist Within The Blood Glucose Monitoring Systems Market?
The blood glucose monitoring systems market covered in this report is segmented –
1) By Type: Non-Invasive, Invasive
2) By Device Type: Continuous Glucose Monitoring Systems, Self-Monitoring Blood Glucose Systems
3) By Testing Site: Fingertip Testing, Alternate Site Testing
4) By Distribution Channel: Institutional Sales, Retail Sales
5) By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes
Subsegments:
1) By Non-Invasive: Optical Sensors, Ultrasound-Based Sensors, Bioimpedance-Based Sensors, Electromagnetic Sensors, Tear Or Saliva-Based Sensors
2) By Invasive: Continuous Glucose Monitoring (CGM) Systems, Self-Monitoring Blood Glucose (SMBG) Systems, Implantable Glucose Monitoring Devices, Flash Glucose Monitoring Systems
How Are Trends Shaping The Direction Of The Blood Glucose Monitoring Systems Market?
Leading companies in the glucose monitoring systems market are focusing on developing innovative solutions, such as advanced hybrid closed-loop systems and smartphone applications for accessing and managing data in real-time. Advanced hybrid closed-loop systems refer to glucose monitoring systems that automatically deliver insulin based on current glucose levels, thus improving blood sugar management for individuals with diabetes. For example, in February 2024, DexCom Inc., a US-based continuous glucose monitoring systems manufacturing company, launched Dexcom ONE+ across various European countries. Dexcom ONE+ incorporates the company’s top-tier sensor technology and features engineered to provide an accessible and highly effective continuous glucose monitoring (CGM) experience for individuals with type 1 or type 2 diabetes who utilize insulin. The system consists of a water-resistant sensor, a transmitter that sends CGM readings, and a Dexcom One smartphone-compatible app. Dexcom ONE+ enables real-time monitoring of blood glucose by the user and up to ten additional people, allowing for shared monitoring.
Which Companies Are Leading Innovation In The Blood Glucose Monitoring Systems Market?
Major companies operating in the blood glucose monitoring systems market are F. Hoffmann-La Roche Ltd., Medtronic plc, Dexcom Inc., SD Biosensor Co. Ltd., Arkray Inc., Abbott Laboratories, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc., GlucoTrack Ltd., Sinocare Inc., Omron Healthcare Co Ltd, Trividia Health Inc.
Read the full blood glucose monitoring systems market report here:
Which Region Is Expected To Register The Fastest Growth In The Blood Glucose Monitoring Systems Market?
North America was the largest region in the blood glucose monitoring systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood glucose monitoring systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Blood Glucose Monitoring Systems Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=17097&type=smp
Browse Through More Reports Similar to the Global Blood Glucose Monitoring Systems Market 2026, By The Business Research Company
Blood Glucose Meters Market Report 2026
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report
Continous Blood Glucose Monitoring Market Report 2026
Continuous Glucose Monitoring Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.